TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers at the University Hospital of Bonn and the University of Bonn reported that direct reprogramming of human red blood cell precursors into neural stem cells reset epigenetic age markers. Cells from an 80-year-old donor had clock readings below 20 years, but the work was conducted in a laboratory and does not show that people can be rejuvenated or treated for age-related disease.
Researchers at the University Hospital of Bonn and the University of Bonn say they directly converted human red blood cell precursors into neural stem cells and observed a substantial reset in markers of cellular age. In the lab study, cells from an 80-year-old donor showed an epigenetic clock reading below 20 years after reprogramming; the result is a finding about cells in a dish, not evidence of rejuvenation in people.
The team used transcription factors to change which genetic instructions the blood-cell precursors followed, directing them toward a neural stem-cell identity. The researchers report that the process also reset epigenetic clocks, which measure age-associated chemical modifications to DNA. These modifications affect how genes are read but do not change the DNA sequence itself.
The conversion was direct: the cells were not first turned into pluripotent stem cells, a more flexible intermediate state, before being guided toward neural development. According to the study account, this route produced a gradual change over weeks that could be followed for more than 100 days. The researchers say the epigenetic age of cells from an 80-year-old donor fell to below 20 years; that clock estimate is not the same as establishing that every feature of an old cell has been reversed.
The findings were published in Aging Cell in a paper titled “Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells.” The study’s DOI is 10.1111/acel.70751. The supplied report describes laboratory cell conversion and clock measurements; it does not report a human treatment or clinical trial.
A Slow Model for Studying Cell Age
The main significance is experimental: a process that unfolds over an extended period may give researchers a way to track when and how age-associated epigenetic marks change as cells acquire a new identity. The Bonn team says that the model could be used to test which factors or substances speed up or slow down this cellular reprogramming. Such work may help clarify the mechanisms behind epigenetic rejuvenation, rather than showing that an intervention is ready for patients.
The research also has potential relevance to neuroscience because the converted cells are neural stem cells, and age is a major risk factor for neurodegenerative conditions such as Alzheimer’s disease. But the study does not establish that the method prevents, treats or reverses those conditions. Any future therapeutic use would require further research on safety, function and performance in relevant biological settings.
As an affiliate, we earn on qualifying purchases.
From Blood Precursors to Neural Stem Cells
Most mature cell types have a specialised role, even though cells in a person share the same genetic information. In laboratory reprogramming, researchers use transcription factors to alter which genes a cell reads, changing its developmental identity. The Bonn team’s stated approach takes blood-cell precursors directly toward a neural stem-cell state rather than routing them through a pluripotent stage.
The report says earlier work by the researchers found that nerve cells made through related methods formed connections with existing neurons after transplantation into mouse brains. That prior result is separate from the current study, which focused on the timing and measurement of age-marker changes during direct conversion. Neither finding, as described in the supplied material, establishes a treatment for people.
““We have directly converted red blood cell precursors into neural stem cells.””
— Prof. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn
As an affiliate, we earn on qualifying purchases.
What Clock Reset Does Not Show
The supplied account does not give details such as the number of donors, the full range of clock measurements, or whether the reported age reset persisted over longer periods. It also does not establish that the converted cells regained every function associated with younger cells, or that clock readings alone capture the full biological effects of aging.
It remains unclear whether the method could be adapted safely and reliably beyond laboratory experiments. The report describes no clinical testing, patient outcomes or evidence that the procedure changes aging in the body. Claims about future applications to Alzheimer’s disease or other conditions would be premature on the information provided.
cell rejuvenation laboratory supplies
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing the Rejuvenation Process
The research team says the slow reset offers a model for examining which biological factors and active substances affect the process. Follow-up work would need to establish how reproducible the effect is across cells and donors, what changes accompany the clock readings, and whether the resulting neural stem cells remain stable and functional.
The study’s publication provides a basis for further laboratory investigation, but the supplied report does not specify a clinical timetable or a planned human trial. For now, the reported development is a research tool and an observation in reprogrammed cells, not a medical procedure available to patients.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the Bonn researchers do?
They directly reprogrammed human red blood cell precursors into neural stem cells in the laboratory and measured age-associated epigenetic marks during the process.
What does a clock reading below 20 years mean?
It refers to an epigenetic age estimate based on DNA modifications. It does not by itself show that the cells, a donor’s body or a person’s health became biologically young in every respect.
Did the study show that the method treats Alzheimer’s disease?
No. The report describes cell reprogramming in a lab, not a treatment test or patient outcome. The possible relevance to neurodegenerative disease is a research rationale, not evidence of clinical benefit.
Why is the gradual process useful to researchers?
The reported change unfolded over weeks and could be monitored for more than 100 days. The researchers say this may let them study which factors influence the resetting of epigenetic age markers.
When could this be used in people?
The supplied report gives no clinical timetable. More laboratory research would be needed, and the study does not establish that the method is safe or effective as a human treatment.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
